Elsevier

Bone

Volume 50, Issue 3, March 2012, Pages 763-770
Bone

Original Full Length Article
Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss

https://doi.org/10.1016/j.bone.2011.12.003Get rights and content

Abstract

Postmenopausal osteoporosis is characterized by a reduction in the numbers of sinusoidal and arterial capillaries in the bone marrow and reduced bone perfusion suggesting a role of vascular component in the pathogenesis of osteoporosis. Previous studies have shown that bone formation and angiogenesis are positively coupled through activation of the hypoxia inducible factor (HIF1α) signaling pathway. Therefore, we hypothesized that mice with increased angiogenesis and osteogenesis due to activation of the HIF signaling pathway in osteoblasts, via osteoblast specific disruption of HIF degrading protein von Hippel–Lindau (VHL) (ΔVhl), are protected from ovariectomy induced bone loss. ΔVhl mice and control littermates were ovariectomized or sham operated and four weeks later bone quality was evaluated along with blood vessel formation. Trabecular and cortical bone volume was strikingly increased in ΔVhl mice along with blood vessel formation as compared to control littermates. In control mice, ovariectomy significantly decreased bone mineral density, deteriorated bone microarchitecture, and decreased mechanical strength compared to the sham operated control mice. This was accompanied with a significant decrease in blood vessel volume and expressions of HIF1α, HIF2α, and VEGF proteins at the distal femur in ovariectomized control mice. In contrast, ovariectomy in ΔVhl mice had absolutely no effect on either the blood vessel formation or the bone structural and mechanical quality parameters. These data indicate that activation of HIF signaling pathway in osteoblasts may prevent estrogen deficiency-induced bone loss and decrease in blood vessels in bone marrow.

Highlights

► Osteoporotic bones display reduced perfusion and numbers of capillaries. ► Bone formation and angiogenesis are coupled through HIF signaling in osteoblasts. ► Active HIF signaling pathway in osteoblasts prevents ovariectomy induced bone loss.

Introduction

Osteoporosis is a skeletal disease characterized by low bone mass and microarchitectural deterioration with a resulting increase in bone fragility and subsequent susceptibility to fractures [1]. The prevalence of osteoporosis increases with increasing age in both men and women with postmenopausal women as a very high risk group [2]. Although the primary cause of postmenopausal osteoporosis is estrogen deficiency [3], it is also characterized by a reduction in the number of sinusoidal and arterial capillaries in the bone marrow and reduced bone perfusion [4], [5], [6] suggesting a role of vascular component in the pathogenesis of postmenopausal osteoporosis. The skeleton is a highly vascularized tissue that receives 5–20% of cardiac output [7]. Developmental studies show that a close coupling between angiogenesis and osteogenesis is essential for normal bone formation [8]. Vascular invasion into cartilage anlagen is essential for long bone formation during endochondral ossification [9]. Moreover, disorders in bone vasculature can affect skeletal homeostasis. For example, impairment of angiogenesis decreases trabecular bone formation as well as the expansion of the hypertrophic zone into the growth plate [10], and surgical interruption of the blood supply to bone results in marked decrease in bone density and strength [11].

On molecular level, developing vasculature and its maintenance is guided by oxygen-gradient and hypoxia-inducible factors (HIFs) [12]. The HIF signaling pathway is also a central regulator of osteogenesis and angiogenesis coupling [13]. The HIF family consists of 3 α subunits, HIF1α, HIF2α, and HIF3α, which form a heterodimer complex with the HIF1β subunit. HIF1β is constitutively expressed whereas HIF-α is an oxygen-labile protein. The α-subunit has an oxygen-dependent degradation domain (ODD) which is recognized by prolyl hydroxylase domain (PHD) proteins. Under normoxic circumstances, PHD proteins hydroxylate HIFα and form a complex with von Hippel–Lindau protein (pVHL), a E3 ubiquitin ligase, that primes HIFα for proteosomal degradation [14]. During hypoxic conditions, prolyl hydroxylation of the α subunit is blocked and HIFα protein accumulates in cytoplasm. It then freely translocates to the nucleus where it heterodimerizes with the β subunit and initiates HIF-responsive genes transcription [15]. Absence of pVHL, and hence the lack of proteosomal degradation of HIFα leads to accumulation of HIFα in the cytoplasm [13], [16], [17] and represents a mechanism to activate HIFα signaling. In-vivo conditional activation of HIFα signaling pathway in osteoblasts by osteoblast-specific deletion of Vhl (ΔVHL) results not only in a dramatic increase in bone mass but also increases the vasculature in bone marrow cavity [13]. Conversely, mice lacking HIF-1α and/or HIF-2α in osteoblasts (ΔHIF) showed a significant decrease in bone volume as well as blood vessel formation [13]. These data reveal a role of HIF signaling in osteoblasts in maintaining bone homeostasis and also in promoting skeletal vascularization. The progressive increase in bone volume in ΔVHL mice results from increased numbers and activity of osteoblasts whereas osteopenia in the ΔHIF is associated with a significant decrease in osteoblast numbers and osteoid volume. However, disruption of Vhl in-vitro does not affect osteoblast proliferation or function indicating that HIF-1α regulates bone formation via cell nonautonomous mechanism. In fact, the amount of bone in these mutant mice is directly proportional to the amount of skeletal vascularity which is proportional to the increased secretion of VEGF by osteoblasts, a downstream target of HIFα signaling.

In this study, we examined whether the skeletal vascularization is decreased in ovariectomized (OVX) mice and whether increasing skeletal blood vessel formation by activation of HIF signaling in osteoblasts can prevent ovariectomy induced bone loss. To answer this question, we used ovariectomized mice with conditional activation of HIFα signaling pathway in osteoblasts by osteoblast-specific deletion of Vhl (ΔVhl) and compared their bone phenotype with normal OVX mice. We have found that skeletal vascularization and bone volume are indeed decreased in OVX mice and the bone loss can be prevented by upregulation of HIF signaling as in ΔVhl mice.

Section snippets

Animal model

All procedures involving mice were approved by the Shanghai Jiaotong University Animal Study Committee and were carried out in accordance with the guide for the humane use and care of laboratory animals. Mice with osteoblast-specific inactivation of Vhl (∆Vhl) were generated by intercrossing osteocalcin-Cre (OC-Cre) transgenic mice [18] with mice homozygous for floxed Vhl allele [19] (both mice kindly provided by Dr. Thomas L. Clemens, Department of Orthopaedic Surgery, Johns Hopkins University

Ovariectomy does not alter body weight in control or ∆Vhl mice

∆Vhl mice were similar in body weight to control littermates before ovariectomy. After the surgery, both control and ∆Vhl ovariectomized (OVX) mice trended to gain a modest weight compared to the respective sham operated group; however, the weight gains were not significantly different (Fig. 1A) indicating minimal stress to the animals due to surgery. Estrogen depletion by ovariectomy resulted in obvious atrophy of uterus in both control and ∆Vhl mice (Figs. 1B and C), and accordingly, the

Discussion

In adults, bone is continuously remodeled throughout life, removing damaged bone and replacing it with new bone and then reconstructing the bone material composition and architecture, to maintain bone strength [21]. During bone remodeling, a precise balance between osteoclastic bone resorption and osteoblastic bone formation is essential in order to maintain the integrity of the bone. Any imbalance in the equilibrium alters bone remodeling that results in osteopetrosis or osteoporosis [22].

Conclusion

Estrogen deficiency induces bone loss and is associated with decreased skeletal vascularization. Here we show that the bones of ovariectomized mice have decreased expression of HIFα and pro-angiogenic factor VEGF leading to decreased bone vasculature along with bone volume. Maintenance of skeletal vasculature by upregulation of HIFα signaling in osteoblasts prevents the estrogen deficiency induced bone loss.

Acknowledgments

The authors thank Thomas L. Clemens for sharing HIF degrading protein von Hippel-Lindau mice. This work was supported by the National Natural Science Foundation of China (Grant No. 30872641), and the Science and Technology Commission of Shanghai Municipality (Grant No. 09DZ2200500).

References (32)

  • T.T. Shih et al.

    Correlation of MR lumbar spine bone marrow perfusion with bone mineral density in female subjects

    Radiology

    (2004)
  • J.F. Griffith et al.

    Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy

    Radiology

    (2005)
  • P. Tothill et al.

    The distribution of blood flow to the whole skeleton in dogs, rabbits and rats measured with microspheres

    Clin Phys Physiol Meas

    (1986)
  • H.P. Gerber et al.

    VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

    Nat Med

    (1999)
  • R.C. Riddle et al.

    Role of hypoxia-inducible factor-1alpha in angiogenic-osteogenic coupling

    J Mol Med

    (2009)
  • G.L. Semenza

    Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1

    Annu Rev Cell Dev Biol

    (1999)
  • Cited by (84)

    • Ferroptosis - A new target of osteoporosis

      2022, Experimental Gerontology
    View all citing articles on Scopus
    1

    These authors contributed equally to this study.

    View full text